Prestige Consumer Healthcare (PBH) Competitors $65.29 +1.40 (+2.19%) Closing price 03:59 PM EasternExtended Trading$65.31 +0.02 (+0.03%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PBH vs. IPAR, HLF, USNA, NUS, NATR, MED, VERU, EL, SNN, and BAXShould you be buying Prestige Consumer Healthcare stock or one of its competitors? The main competitors of Prestige Consumer Healthcare include Interparfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estee Lauder Companies (EL), Smith & Nephew SNATS (SNN), and Baxter International (BAX). Prestige Consumer Healthcare vs. Its Competitors Interparfums Herbalife USANA Health Sciences Nu Skin Enterprises Nature's Sunshine Products Medifast Veru Estee Lauder Companies Smith & Nephew SNATS Baxter International Interparfums (NASDAQ:IPAR) and Prestige Consumer Healthcare (NYSE:PBH) are both mid-cap personal products companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership. Is IPAR or PBH more profitable? Prestige Consumer Healthcare has a net margin of 19.02% compared to Interparfums' net margin of 11.03%. Interparfums' return on equity of 16.45% beat Prestige Consumer Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Interparfums11.03% 16.45% 11.14% Prestige Consumer Healthcare 19.02%12.69%6.79% Do insiders & institutionals hold more shares of IPAR or PBH? 55.6% of Interparfums shares are held by institutional investors. Comparatively, 100.0% of Prestige Consumer Healthcare shares are held by institutional investors. 43.7% of Interparfums shares are held by insiders. Comparatively, 1.4% of Prestige Consumer Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, IPAR or PBH? Interparfums has a beta of 1.43, meaning that its stock price is 43% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500. Which has better valuation & earnings, IPAR or PBH? Prestige Consumer Healthcare has lower revenue, but higher earnings than Interparfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInterparfums$1.45B2.58$164.36M$4.9923.34Prestige Consumer Healthcare$1.14B2.82$214.60M$4.2615.33 Does the media refer more to IPAR or PBH? In the previous week, Prestige Consumer Healthcare had 16 more articles in the media than Interparfums. MarketBeat recorded 28 mentions for Prestige Consumer Healthcare and 12 mentions for Interparfums. Interparfums' average media sentiment score of 0.28 beat Prestige Consumer Healthcare's score of 0.04 indicating that Interparfums is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Interparfums 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Prestige Consumer Healthcare 7 Very Positive mention(s) 1 Positive mention(s) 10 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Neutral Do analysts recommend IPAR or PBH? Interparfums currently has a consensus target price of $162.00, indicating a potential upside of 39.09%. Prestige Consumer Healthcare has a consensus target price of $93.33, indicating a potential upside of 42.95%. Given Prestige Consumer Healthcare's higher possible upside, analysts plainly believe Prestige Consumer Healthcare is more favorable than Interparfums.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Interparfums 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Prestige Consumer Healthcare 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryInterparfums beats Prestige Consumer Healthcare on 10 of the 16 factors compared between the two stocks. Get Prestige Consumer Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBH vs. The Competition Export to ExcelMetricPrestige Consumer HealthcareMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$3.14B$10.58B$5.50B$20.66BDividend YieldN/A2.01%4.64%3.66%P/E Ratio15.3319.8030.3928.37Price / Sales2.8224.76447.5260.19Price / Cash12.2523.7337.7222.93Price / Book1.733.038.305.38Net Income$214.60M$211.77M$3.26B$994.60M7 Day Performance-11.83%3.91%0.91%1.50%1 Month Performance-14.46%6.33%3.66%0.49%1 Year Performance0.04%-7.10%46.29%18.07% Prestige Consumer Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBHPrestige Consumer Healthcare4.368 of 5 stars$65.29+2.2%$93.33+43.0%-3.3%$3.14B$1.14B15.33540Earnings ReportAnalyst DowngradeAnalyst RevisionIPARInterparfums4.4275 of 5 stars$119.95+1.4%$162.00+35.1%-12.1%$3.80B$1.45B23.34530Earnings ReportDividend AnnouncementHLFHerbalife4.4683 of 5 stars$9.56+4.6%$11.50+20.2%+1.1%$930.88M$4.95B3.498,600Earnings ReportAnalyst DowngradeUSNAUSANA Health Sciences4.1417 of 5 stars$29.11+0.8%$36.00+23.7%-24.7%$537.46M$854.50M16.171,700NUSNu Skin Enterprises4.1231 of 5 stars$8.32+1.4%$6.88-17.3%+5.0%$405.19M$1.68B-10.393,100News CoverageEarnings ReportDividend AnnouncementAnalyst DowngradeNATRNature's Sunshine Products2.6553 of 5 stars$15.50-1.9%$19.67+26.9%+27.5%$278.64M$454.36M20.95850Positive NewsHigh Trading VolumeMEDMedifast4.2095 of 5 stars$13.50-1.8%$16.50+22.2%-34.3%$151.13M$602.46M-20.77870VERUVeru1.8392 of 5 stars$0.48-2.7%$4.00+732.6%-56.4%$72.34M$16.89M-2.00230Trending NewsEarnings ReportStock SplitGap DownELEstee Lauder Companies4.1708 of 5 stars$92.52+1.6%$84.50-8.7%+0.1%$32.75B$15.61B-38.2362,000News CoveragePositive NewsSNNSmith & Nephew SNATS2.2349 of 5 stars$30.79-0.1%$28.00-9.1%+20.4%$13.50B$5.81B14.2617,349Positive NewsDividend CutBAXBaxter International4.8153 of 5 stars$22.41+2.0%$30.11+34.4%-36.8%$11.27B$10.64B-74.7038,000 Related Companies and Tools Related Companies IPAR Competitors HLF Competitors USNA Competitors NUS Competitors NATR Competitors MED Competitors VERU Competitors EL Competitors SNN Competitors BAX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PBH) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredThis New Rule Could Change EverythingA new rule taking effect this September has Big Banks shifting billions into one asset they now treat like cas...American Alternative | SponsoredElon Musk: “Nothing happens without this…”Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...Behind the Markets | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prestige Consumer Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prestige Consumer Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access